| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/13/2006 | CN1830443A Preparation method of sophora flavescens freeze dried powder injection |
| 09/13/2006 | CN1830284A Tea and its preparation method |
| 09/13/2006 | CN1830279A Dried orange peel health-care tea |
| 09/13/2006 | CN1830275A Dry milk piece with astragalus mongholicus for protecting stomach |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274712C Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274687C Suitqable to industrialized method for preparing emtricitabine |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274668C Salts of nateglinide |
| 09/13/2006 | CN1274363C Auxiliary therapeutic agent for C type hepatitis |
| 09/13/2006 | CN1274357C Chinese patent drug for treatnig liver fibration and cirrhosis, preparing method for its preparation |
| 09/13/2006 | CN1274356C Composite Chinese medicine for treating heptic fibrosis and cirrhosis due to hepatitis B and its mfg. method |
| 09/13/2006 | CN1274354C Method for preparing medication for preventing and treating infantile malnutrition |
| 09/13/2006 | CN1274353C Medication for curing children's infantile malnutrition and preparation method |
| 09/13/2006 | CN1274351C Medicine combination for treating child fastidium |
| 09/13/2006 | CN1274344C Pure Chinese medicine preparation for parodontium anaesthesia and its preparing process |
| 09/13/2006 | CN1274334C Combination of medication for relieving diarrhea, and preparation method thereof |
| 09/13/2006 | CN1274330C Stomachache paster and preparing process thereof |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105676 Tetrahydropyridoethers |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105577 Antimicrobial method using a hydroxydiphenyl ether compound |
| 09/12/2006 | US7105558 Gastrin and cholecystokinin receptor lignads (iv) |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105527 such as beta-D-N4-p-bromobenzoyl-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine; for treating human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105303 Antibodies to hepatitis C virus asialoglycoproteins |
| 09/12/2006 | US7105167 Administering variants of insulin-like growth factor I to treat hyperglycemic disorder, congestive heart failure, urogenital disorders, poor nutrition, or a wasting syndrome |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/08/2006 | WO2006094063A1 Quinolinone compounds as 5-ht4 receptor agonists |
| 09/08/2006 | WO2006093774A2 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093143A1 Model for nash or liver tumor, method for production of the model, method for screening of therapeutic agent for nash or liver tumor, method for analysis of mechanism for development of nash or liver tumorm, and agent for prevention or treatment of nash |
| 09/08/2006 | WO2006092893A1 Enterokinesis promoting compound |
| 09/08/2006 | WO2006092617A1 Crystallisation and purification of glycopyrronium bromide |
| 09/08/2006 | WO2006092209A1 Novel targets and compounds useful in the treatment of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds |
| 09/08/2006 | CA2601129A1 Crystallisation and purification of glycopyrronium bromide |
| 09/08/2006 | CA2599404A1 Quinolinone compounds as 5-ht4 receptor agonists |
| 09/08/2006 | CA2599379A1 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199797 Using compounds such as 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N {(R)- alpha -[N ((R)-1-carboxy-2-methylthio -ethyl)carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine for therapy of Irritable Bowel Syndrome |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060198898 Orally administering edible oil homogenized with an edible wax at a concentration ranging from 0.5% to 50% by weight and a sterol compound at a concentration of at least 0.1% by weight for repairing and promoting regeneration of mucosa in the GI tract |
| 09/07/2006 | US20060198790 Buccal, polar and non-polar spray containing ondansetron |
| 09/07/2006 | DE19526233B4 Hydroxylierte Azabicyclooctyl-tetra- und -hexahydrobenz[d,e]isochinolone, deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten Hydroxylated Azabicyclooctyl tetra- and -hexahydrobenz [e] isochinolone, their preparation and pharmaceutical compositions containing these |
| 09/07/2006 | DE102005008412A1 New piperazine salt of omeprazol is proton pump inhibitor useful to prevent/treat e.g. peptic ulcer, gastritis, gastroesophageal reflux, acute stress ulcer or dyspepsia |
| 09/07/2006 | CA2496637A1 Treatment of inflammatory conditions of the intestine using high density lipoprotein |
| 09/06/2006 | EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697517A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 09/06/2006 | EP1697360A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt. |
| 09/06/2006 | EP1696947A1 Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| 09/06/2006 | EP1696937A1 Prebiotic combination products |
| 09/06/2006 | EP1696921A1 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 09/06/2006 | EP1696916A1 Use of metabotropic glutamate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 09/06/2006 | EP1696911A1 Intranasal compositions |
| 09/06/2006 | EP1696910A1 Compositions and methods for treatment of fibrosis |
| 09/06/2006 | EP1696737A1 Edible compositions which are adapted for use by a companion animal |
| 09/06/2006 | EP1696734A1 Methods and kits related to administration of a fructooligosaccharide |
| 09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 09/06/2006 | EP1510136B1 Process for producing lactulose-containing powder composition, lactulose-containing powder composition obtained by the process and feed additive |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | CN1829689A Benzylamine derivative |
| 09/06/2006 | CN1827766A In vitro cell cultivation method |
| 09/06/2006 | CN1827640A Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 09/06/2006 | CN1827634A Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof |
| 09/06/2006 | CN1827627A Novel acyclic nucleoside phosphonic acid and its ester derivatives and pharmaceutical use thereof |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1827164A Animal medicine capable of rehabilitating intestinal tract injury |